IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferguson, J. S.
Right arrow Articles by Schlesinger, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferguson, J. S.
Right arrow Articles by Schlesinger, L. S.
Infection and Immunity, May 2004, p. 2564-2573, Vol. 72, No. 5
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.5.2564-2573.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Complement Protein C3 Binding to Mycobacterium tuberculosis Is Initiated by the Classical Pathway in Human Bronchoalveolar Lavage Fluid

J. Scott Ferguson,1,2* Jeremy J. Weis,2,3,{dagger} Jennifer L. Martin,1,2 and Larry S. Schlesinger2,3,4*

Division of Pulmonary and Critical Care Medicine,1 Division of Infectious Diseases,3 Department of Internal Medicine,2 Department of Microbiology, Interdisciplinary Immunology Program, Iowa City Veterans Affairs Medical Center and the University of Iowa, Iowa City, Iowa, 522424

Received 3 July 2003/ Returned for modification 4 November 2003/ Accepted 26 January 2004

In high concentrations of fresh nonimmune human serum, Mycobacterium tuberculosis activates the alternative pathway of complement and binds C3 protein, resulting in enhanced phagocytosis by complement receptors on human alveolar macrophages. Yet in the lung, the alternative pathway of complement is relatively inactive compared to the classical pathway. To begin to determine whether C3 opsonophagocytosis of M. tuberculosis by alveolar macrophages can occur in the lung of the immunologically naive host, we characterized the binding of C3 to M. tuberculosis in different concentrations of fresh nonimmune human serum and concentrated human bronchoalveolar lavage fluid. Here we show that in human serum, C3 binding to M. tuberculosis is rapid, initiated by either the alternative pathway or the classical pathway, depending on the concentration of serum, and occurs by covalent linkages between the bacterial surface and the C3 cleavage products, C3b or C3bi. Human bronchoalveolar lavage fluid contains C3 protein and functional classical pathway activity that mediates the binding of C3 to the surface of M. tuberculosis. These studies provide evidence that when M. tuberculosis is first inhaled into the lungs of the human host, the bacterium is opsonized by C3 cleavage via classical pathway activation within the alveolus, providing a C3-dependent entry pathway into resident alveolar macrophages.


* Corresponding authors. Mailing address for J. Scott Ferguson: Division of Pulmonary and Critical Care Medicine, C-33 GH, 200 Hawkins Dr., Iowa City, IA 52242. Phone: (319) 384-9832. Fax: (319) 353-6406. E-mail: john-s-ferguson{at}uiowa.edu. Present address for Larry S. Schlesinger: Division of Infectious Diseases and the Center for Microbial Interface Biology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210. Phone: (614) 293-5671. Fax: (614) 293-4556. E-mail: schlesinger-2{at}medctr.osu.edu.

Editor: S. H. E. Kaufmann

{dagger} Present address: 909 Catawba Cir., Columbia, SC 29201.


Infection and Immunity, May 2004, p. 2564-2573, Vol. 72, No. 5
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.5.2564-2573.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2004 by the American Society for Microbiology. All rights reserved.